GHRH antagonists: a novel therapy for non-Hodgkin's lymphoma

被引:0
|
作者
Vicky Heath
机构
来源
Nature Clinical Practice Endocrinology & Metabolism | 2005年 / 1卷 / 1期
关键词
D O I
10.1038/ncpendmet0006
中图分类号
学科分类号
摘要
引用
收藏
页码:8 / 8
相关论文
共 50 条
  • [1] Chemokines and antagonists in non-Hodgkin's lymphoma
    Golay, Josee
    Introna, Martino
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 621 - 635
  • [2] Therapy of non-Hodgkin's lymphoma
    Coffey, J.
    Hodgson, D. C.
    Gospodarowicz, M. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S28 - S36
  • [3] Therapy of non-Hodgkin's lymphoma
    J. Coffey
    D. C. Hodgson
    M. K. Gospodarowicz
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S28 - S36
  • [4] Blinatumomab: a novel therapy for the treatment of non-Hodgkin?s lymphoma
    Bukhari, Ali
    Lee, Seung Tae
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (11) : 909 - 918
  • [5] Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
    Grover, Natalie S.
    Park, Steven I.
    PHARMACEUTICALS, 2015, 8 (03) : 607 - 636
  • [6] Rituximab for the therapy of non-Hodgkin's lymphoma
    Rummel, M. J.
    ONKOLOGE, 2007, 13 (03): : 227 - +
  • [7] Antibody therapy for non-Hodgkin's lymphoma
    Ansell, SM
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (02) : 175 - 181
  • [8] Hodgkin's and Non-Hodgkin's Lymphoma
    Manning, Jaye
    CANCER FORUM, 2007, 31 (02) : 117 - 117
  • [9] Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
    Ruan, J.
    Hajjar, K.
    Rafii, S.
    Leonard, J. P.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 413 - 424
  • [10] History of antibody therapy for non-Hodgkin's lymphoma
    Forero, A
    LoBuglio, AF
    SEMINARS IN ONCOLOGY, 2003, 30 (06) : 1 - 5